MSI

Clinical trials for MSI explained in plain language.

Never miss a new study

Get alerted when new MSI trials appear

Sign up with your email to follow new studies for MSI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Cancer drug combo trial pulled before it even started

Disease control Terminated

This was a planned Phase 2 trial to test two immunotherapy drugs—monalizumab and MEDI5752—in people with metastatic cancers that have a specific genetic feature called MSI/dMMR. The study was withdrawn before enrolling any participants, so no data or results are available. The go…

Matched conditions: MSI

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

MSI

Get alerted when new MSI trials appear

Cancer drug combo trial pulled before it even started